Optimizing 131I-mIBG Dosimetry: Validation of Simplified Time-Point and Segmentation Approaches
Abstract Purpose To evaluate simplified dosimetry methods for 131 I-mIBG therapy that maintain agreement with reference method while reducing clinical workflow burdens, particularly beneficial for pediatric applications. Methods In 24 patients, we implemented a hybrid protocol combining planar whole-body scans (1, 24, 48 h p.i.) with 24 h SPECT/CT for whole-body and liver dosimetry. Three liver segmentation methods were compared on SPECT/CT: whole-organ manual delineation (reference), 4 mL homogeneous sphere, and 4 mL peak sphere. To estimate time-integrated activity coefficients (TIACs) we modeled biokinetics with monoexponential using: full three-time-point data (reference), reduced combinations (1–2, 1–3, 2–3), Hänscheid single-time-point method, and population-based half-lives. Statistical analysis included linear mixed-effects modeling for segmentation comparisons and Bland-Altman analysis for TIAC method validation. Results The median absorbed dose was 0.36 mGy/MBq for liver and 0.09 mGy/MBq for whole-body. Among simplified protocols, dual-time-point 24–48 h imaging demonstrated the least bias, with liver absorbed doses showing − 0.02 mGy/MBq (limits of agreement: -0.08 to 0.04 mGy/MBq) and whole-body absorbed doses 0.001 mGy/MBq (limits of agreement: -0.004 to 0.005 mGy/MBq) compared to the full three-time-point reference results. Among single-time-point methods, for both liver and whole-body, the Hänscheid approach applied at 48 h demonstrated superior performance. The 4 mL peak sphere overestimated absorbed doses by 69% versus whole-organ delineation (0.61 vs. 0.36 mGy/MBq, p < 0.001), and homogeneous spheres underestimated by 8% (0.33 vs. 0.36 mGy/MBq, p = 0.046). Conclusions Clinically feasible 131 I-mIBG dosimetry can be achieved through: (1) dual 24 h/48 h imaging (< 6% mean bias), (2) single 48 h Hänscheid method (< 6% mean bias), and (3) homogeneous sphere liver segmentation ( < 8% mean difference from reference).
Authors
- Sara Kurkowska (ORCID: https://orcid.org/0000-0001-5101-8911)
- Hanna Piwowarska-Bilska (ORCID: https://orcid.org/0000-0003-3617-7687)
- Bożena Birkenfeld (ORCID: https://orcid.org/0000-0003-1174-8199)
- Carlos Uribe (ORCID: https://orcid.org/0000-0003-3127-7478)
- Małgorzata Poniatowska (ORCID: https://orcid.org/0000-0003-2632-7186)
Institutions
- BC Cancer Agency (CA)
- Spinal Cord Injury BC (CA)
- Pomeranian Medical University (PL)
Publication Details
- Journal
- Nuclear Medicine and Molecular Imaging
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1007/s13139-025-00959-5
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00